AllianceBernstein’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,244,815
| Closed | -$4.73M | – | 3313 |
|
|
2020
Q1 | $4.73M | Buy |
1,244,815
+674,813
| +118% | +$2.91M | ﹤0.01% | 1212 |
|
|
2019
Q4 | $2.9M | Buy |
570,002
+450,500
| +377% | +$2.38M | ﹤0.01% | 1755 |
|
|
2019
Q3 | $604K | Sell |
119,502
-18,950
| -14% | -$94.5K | ﹤0.01% | 2470 |
|
|
2019
Q2 | $854K | Buy |
138,452
+42,500
| +44% | +$205K | ﹤0.01% | 2381 |
|
|
2019
Q1 | $445K | Buy |
95,952
+14,600
| +18% | +$66.1K | ﹤0.01% | 2565 |
|
|
2018
Q4 | $342K | Hold |
81,352
| – | – | ﹤0.01% | 2662 |
|
|
2018
Q3 | $510K | Hold |
81,352
| – | – | ﹤0.01% | 2609 |
|
|
2018
Q2 | $654K | Sell |
81,352
-13,300
| -14% | -$102K | ﹤0.01% | 2515 |
|
|
2018
Q1 | $706K | Hold |
94,652
| – | – | ﹤0.01% | 2409 |
|
|
2017
Q4 | $563K | Hold |
94,652
| – | – | ﹤0.01% | 2495 |
|
|
2017
Q3 | $697K | Hold |
94,652
| – | – | ﹤0.01% | 2457 |
|
|
2017
Q2 | $643K | Sell |
94,652
-145,780
| -61% | -$1.08M | ﹤0.01% | 2510 |
|
|
2017
Q1 | $2.27M | Sell |
240,432
-213,410
| -47% | -$2.13M | ﹤0.01% | 1724 |
|
|
2016
Q4 | $3.92M | Buy |
453,842
+344,890
| +317% | +$2.55M | ﹤0.01% | 1350 |
|
|
2016
Q3 | $690K | Hold |
108,952
| – | – | ﹤0.01% | 2388 |
|
|
2016
Q2 | $460K | Sell |
108,952
-35,700
| -25% | -$172K | ﹤0.01% | 2547 |
|
|
2016
Q1 | $631K | Buy |
144,652
+42,170
| +41% | +$188K | ﹤0.01% | 2329 |
|
|
2015
Q4 | $628K | Buy |
102,482
+730
| +0.7% | +$4.79K | ﹤0.01% | 2358 |
|
|
2015
Q3 | $582K | Hold |
101,752
| – | – | ﹤0.01% | 2431 |
|
|
2015
Q2 | $759K | Buy |
101,752
+10,700
| +12% | +$64.7K | ﹤0.01% | 2421 |
|
|
2015
Q1 | $544K | Hold |
91,052
| – | – | ﹤0.01% | 2456 |
|
|
2014
Q4 | $688K | Hold |
91,052
| – | – | ﹤0.01% | 2386 |
|
|
2014
Q3 | $473K | Hold |
91,052
| – | – | ﹤0.01% | 2525 |
|
|
2014
Q2 | $392K | Buy |
91,052
+34,529
| +61% | +$132K | ﹤0.01% | 2588 |
|
|
2014
Q1 | $231K | Buy |
56,523
+10,700
| +23% | +$54.7K | ﹤0.01% | 2715 |
|
|
2013
Q4 | $244K | Sell |
45,823
-10,300
| -18% | -$45.3K | ﹤0.01% | 2740 |
|
|
2013
Q3 | $282K | Sell |
56,123
-10,304
| -16% | -$55.9K | ﹤0.01% | 2751 |
|
|
2013
Q2 | $296K | Buy |
+66,427
| New | +$298K | ﹤0.01% | 2719 |
|
Other funds holding PGNX
AllianceBernstein's PGNX Position: Q2 2020 in Review
AllianceBernstein sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 1,244,815 shares — an estimated $4.73M sold.
AllianceBernstein first reported a position in PGNX in Q2 2013 and held it in 28 quarters. The position peaked at $4.73M in Q1 2020. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.
- AllianceBernstein reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
- AllianceBernstein sold 1,244,815 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $4.73M.
- AllianceBernstein first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 28 quarters.
- AllianceBernstein's Progenics Pharmaceuticals Inc position peaked at $4.73M in Q1 2020.
- 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.
Based on AllianceBernstein's 13F filing for Q2 2020, filed 13 Aug 2020.